INTRODUCTION
P seudoexfoliation (PXF) syndrome is a systemic disorder of unknown etiology with the potential for many intraocular complications [1] . PXF is an age-related disorder characterized by the production and accumulation of an abnormal PXF fibrillar material in various ocular tissues [2] .
PXF material accumulations mechanically weaken the zonular lamellae and impair zonular anchoring to the ciliary epithelial basement membrane at both its origin and insertion [3] . In addition, previous studies have demonstrated that higher cataract grade and shallower preoperative anterior chamber are key risk factors for endothelial cells reduction after cataract surgery in eyes with PXF [3] [4] [5] [6] [7] . Although the prevalence described varies between series in different countries and specific populations [1, 8] , it has been reported this syndrome affects about 0.2%-30% of people older than 60y worldwide [8] . PXF remains an important risk factor related to ocular complications during cataract surgery due to its association with high intraocular pressure (IOP), reduced pupil dilation and zonular weakness [9] [10] . Pseudoexfoliation glaucoma (PXG) is the most common form of secondary open angle glaucoma and develops in the context of PXF [11] [12] . Glaucoma frequently occurs in eyes with PXF syndrome and compared to primary open angle glaucoma (POAG), optic damage is more pronounced in these eyes at the time of diagnosis, and response to medical therapy is poorer [13] . Previous series have demonstrated that postoperative IOP is directly related with preoperative IOP values [14] [15] : the higher the preoperative IOP, the greater the postoperative IOP reduction [15] [16] . In addition, recent studies on controlled POAG patients have demonstrated a modest decrease in IOP after undergoing phacoemulsification surgery [17] . However, it has been suggested that changes in IOP after cataract surgery can be different among glaucoma types and ethnic groups [17] [18] .
POAG and PXG are the most common types of chronic open angle glaucoma worldwide [6] ; and it has been described that uncomplicated phacoemulsification with posterior chamber intraocular lens (IOL) implantation surgery alone lowers IOP and reduces their need for anti-glaucomatous drugs [3] [4] . The purpose of this study was to determine long-term reduction in IOP and glaucoma medications use after routine cataract phacoemulsification surgery in patients with PXG in comparison to those with POAG.
SUBJECTS AND METHODS Study Design
This retrospective, observational and comparative study was approved by the Internal Review Board of the Association to Prevent Blindness in Mexico. All the procedures conformed to the tenets of the Declaration of Helsinki. All participants signed a written informed consent before surgical procedures were performed. Patients The medical records of patients with a diagnosis of POAG or PXG that underwent phacoemulsification cataract surgery from January 2014 to January 2016 at the Glaucoma Department of the Association to Prevent Blindness in Mexico were analyzed. Data collected from records included: age, gender, IOP at all time intervals, and medication used. This analysis comprised eyes of consecutive patients that had routine phacoemulsification surgery. Eligibility criteria included: age ≥50y, diagnosis of POAG or exfoliative glaucoma (XFG) in the presence of a cataract that decreased visual acuity and evidence of glaucomatous optic nerve changes and/or visual field defects related to glaucoma damage, with an IOP of ≤25 mm Hg. All patients were diagnosed with glaucoma using functional and/ or structural studies. Functional studies included 24-2 visual fields (Humphrey © Field Analyzer 750i, Carl Zeiss, Germany).
In addition, optical coherence tomography (Cirrus © HD OCT, Carl Zeiss, Germany) was employed for structural analysis. All eyes were examined before surgery, including a complete slit-lamp evaluation under pharmacological pupil dilation. Figure 1 depicts the effect of phacoemulsification cataract surgery on the mean IOP at each time interval. There was a statistically significant reduction in IOP compared to preoperative values at all time intervals from 1 to 12mo postoperatively. In the POAG group, IOP diminished compared to baseline at all time points (Table 2) . The decrease was significantly greater than in the PXG group at 3, 6 and 12mo postoperatively. A significant difference in the mean ΔIOP was evidenced between groups as shown in Table 3 .
In the PXG group the mean IOP before surgery was 17.9 mm Hg with a mean of 2.06 medications used, which decreased to a mean of 14.25 mm Hg postoperatively with a mean of 1.35 medications used after 12mo of follow-up, which represents a 20.3%, and a 34.46% decrease in IOP and number of medications used, respectively. The mean IOP before surgery in the POAG group was 15.9 mm Hg with a mean of 2.3 medications used, which decreased to 13.1 mm Hg with a mean of 1.1 medications used during the 12mo follow-up. This represents a 20.0% decrease in IOP, and a 56.5% reduction in the number of medications used. Preoperatively, 34 patients in the PXG group required glaucoma medications. During the 12mo follow-up, the number of medications used diminished in all patients and also 10 patients discontinued medication use due to IOP decrease. No patient required additional glaucoma medications postoperatively. DISCUSSION In our study, the mean postoperative IOP at 12mo was significantly lower than the respective preoperative values. Moreover, the mean ΔIOP difference was also statistically significant between groups (P<0.0001). This difference suggests that despite the reduction of the postsurgical IOP mean values in both groups, the POAG group showed a greater reduction in IOP values compared to the PXG group. Our findings agree with previous studies that documented an improvement in glaucoma control after phacoemulsification. Mierzejewski et al [19] , reported in PXG patients, a decrease in IOP from 20.6 to 15.1 mm Hg (a 27% reduction; P<0.00001). In addition, the number of medications used decreased from 1.7 to 1.2, similar to our results [12] . Also reported a 5% increase in postoperative IOP, but the glaucoma severity was not reported and therefore poorly controlled patients may have minor improvements postoperatively. Other series have demonstrated a greater IOP reduction postoperatively in elderly patients, females, eyes with an axial length ≤21 mm, and PXF patients [17] [18] 20] . However, it has been described that in patients with certain types of glaucoma, mean IOP may be reduced up to 5.5 mm Hg [16, 18] . A recent Metaanalysis evaluated the impact of phacoemulsification on IOP in glaucoma patients, which reported that in POAG patients who are controlled with 1 or 2 medications, phacoemulsification alone results in a modest decrease in IOP (13%) as well as in medication use (12%) [17] . Furthermore, this analysis reported that incisional glaucoma surgery would be rarely necessary for IOP control within 1y [17] [18] . In patients with mild to moderate PXG controlled with 1 or 2 medications, phacoemulsification results in a moderate decrease in IOP (20%) and in the number of medications required after surgery (35%) [18] . Shingleton et al [21] studied 240 eyes, also with medically controlled PXG, in patients who underwent uncomplicated phacoemulsification. The extent of glaucoma damage was not reported. Among 51 eyes with a follow-up of 60mo, the IOP decreased from 18.0 to 16.9 mm Hg (6%; P<0.030), and the number of medications used decreased from a mean of 1.6 to 1.0 (38%), similar to the reduction obtained in the PXG group in our study. In addition, among studies including PXG and non-PXG patients, Peräsalo [22] , retrospectively studied 182 Finnish patients (226 eyes) with medically controlled PXG (n=124) and POAG (n=102) who underwent phacoemulsification cataract surgery. The IOP decreased from 17.1 to15.3 mm Hg (P<0.001) at 12mo of follow-up. The number of medications used decreased from a mean of 1.5 to 0.9 (40%); but 37% of the patients in the study required an increase in medications [22] . This study included PXG and POAG patients, and reported similar reductions both in IOP and in postoperative medication use; however, no significant differences were evidenced between groups. Similarly, Elguin et al [3] reported no significant differences in postoperative IOP measurements between PXG and POAG patients undergoing uneventful cataract surgery. Several studies have shown that the decrease in IOP after phacoemulsification is more pronounced in eyes with a higher preoperative IOP [16] . However, few studies have evaluated the postoperative IOP response in patients with PXG compared to those with POAG. It has been suggested that phacoemulsification removes a source of PXF material (the anterior lens capsule) and results in or stimulates clearance of PXF and pigment debris from the anterior segment, in particular the trabecular meshwork [1] . Various IOP reduction mechanisms after phacoemulsification have been proposed, however, the key mechanism may vary across different types of glaucoma [23] . IOP drop following phacoemulsification has been shown to be greater in patients with PXF [17] . In addition, it has been described that IOP response after phacoemulsification surgery in patients with PXF correlated with the volume of irrigation fluid used intraoperatively, thus reinforcing the idea that the procedure may remove exfoliation material from the outflow system [17, 24] . This study has some limitations that should be noted, one of the main weaknesses of this study is its retrospective nature with the inherent limitations of data extrapolation, and therefore subject to the selection bias of such a study. In addition, this study examined IOP alone and did not evaluate the status of the optic nerve head, nerve fiber layer, or visual fields in the disease population. In summary, our findings suggest that inpatients diagnosed with PXG or POAG, controlled with 1 or 2 medications and IOP >25 mm Hg, cataract phacoemulsification surgery results in a significant decrease in IOP, as well as in the number of medications required after surgery. Therefore, early cataract surgery may be considered for the treatment of patients with a visually significant cataract and glaucoma as a reasonable surgical option in patients with coexisting cataract and relatively well-controlled glaucoma. 
